Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bayzed Health GroupHKSE:02609 +0.90%12 Receivables Turnover is 2.50 as of Dec. 2025. GuruFocus rates HKSE:02609 with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 663 Healthcare Providers & Services companies, Bayzed Health Group ranks worse than 72.55% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Bayzed Health Group's Revenue for the
six
months ended in Dec. 2025 was HK$602 Mil. Bayzed Health Group's average Accounts Receivable for the
six
months ended in Dec. 2025 was HK$240 Mil.
Hence, Bayzed Health Group's Receivables Turnover for the
six
months ended in Dec. 2025 was 2.50.
Bayzed Health Group (HKSE:02609) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Bayzed Health Group Receivables Turnover Related Terms
Bayzed Health Group Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Bayzed Health Group's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02609 vs HCA, THC, EHC: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Bayzed Health Group's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bayzed Health Group Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bayzed Health Group's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Bayzed Health Group's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bayzed Health Group (HKSE:02609) has a Receivables Turnover of 2.50 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Bayzed Health Group and its competitors. According to the industry distribution chart, Bayzed Health Group ranks #481 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 72.5%.
Is Bayzed Health Group's Receivables Turnover too high?
Bayzed Health Group's current Receivables Turnover is 2.50. The Healthcare Providers & Services industry median Receivables Turnover is 7.98. Bayzed Health Group's value of 2.50 is 68.7% below this industry median. Based on the distribution chart, Bayzed Health Group ranks #481 out of 663 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Bayzed Health Group has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bayzed Health Group's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bayzed Health Group ranks #481 out of 663 companies for Receivables Turnover. This places Bayzed Health Group in the lower half of its industry. The industry median Receivables Turnover is 7.98. Bayzed Health Group's value of 2.50 is 68.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.98, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bayzed Health Group's current Receivables Turnover of 2.50 is 68.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Bayzed Health Group and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bayzed Health Group's current Receivables Turnover is 2.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayzed Health Group stock overvalued right now?
Bayzed Health Group (HKSE:02609) has a current Receivables Turnover of 2.50. The current Receivables Turnover is 2.50 and 68.7% below the Healthcare Providers & Services industry median of 7.98. Bayzed Health Group's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Bayzed Health Group (HKSE:02609), the current Receivables Turnover is 2.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bayzed Health Group Inc is an oncology healthcare group that principally engages in the investment in, and provision of, medical and healthcare related services in the PRC. It operates and manages a network of eight hospitals in Beijing, Tianjin, Shanxi Province, Anhui Province, and Henan Province, with a strategic focus on the provision of full-cycle oncology healthcare services through its direct ownership of the equity interest in six private for-profit hospitals and management over two private not-for-profit hospitals.
12GF Score
Get the complete analysis for HKSE:02609
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02609 has been successfully added to your 
